サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1298599

ニードルフリードラッグデリバリー技術市場：製品、用途、エンドユーザー、地域別2023-2028年

Needle-free Drug Delivery Technology Market by Product, Application, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニードルフリードラッグデリバリー技術市場：製品、用途、エンドユーザー、地域別2023-2028年
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のニードルフリードラッグデリバリー技術市場規模は、2022年に41億8,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて5.22%の成長率（CAGR）を示し、2028年までに57億2,000万米ドルに達すると予測しています。慢性疾患の蔓延、老人人口の増加、レーザーによるニードルフリー注射技術（NFIT）の最近の市場開拓は、市場を牽引する主な要因の一つです。

ニードルフリードラッグデリバリー技術とは、従来の注射針を使わずに患者に薬剤を投与する方法を指します。これには、マイクロノズル・ジェット・インジェクター、経皮パッチ、吸入器、使い捨てカートリッジ・インジェクター、点鼻スプレー、超音波などが含まれます。これらは予防接種、インスリン投与、疼痛管理、ホルモン療法、アレルギー、がん、呼吸器疾患、その他の慢性疾患の治療に広く使われています。従来の針を使用したデリバリーシステムと比較して、針を使用しないドラッグデリバリー技術は痛みを軽減し、不快感や不安を最小限に抑え、利便性を高め、患者のコンプライアンスを向上させ、投与量のカスタマイズを可能にし、怪我や感染のリスクを防止します。また、より迅速なドラッグデリバリーを実現し、薬剤の吸収を促進し、合併症を最小限に抑え、治療効果を高めます。ニードルフリードラッグデリバリー技術は、有害廃棄物の発生を最小限に抑え、製造時の排出を削減し、製品の廃棄の必要性をなくすため、環境にも優しいです。

ニードルフリードラッグデリバリー技術の市場動向：

糖尿病、がん、クローン病、多発性硬化症、関節炎、骨粗鬆症、心血管疾患（CVDs）などの慢性疾患の有病率の上昇は、市場成長を促進する主な要因の1つです。針を使用しないドラッグデリバリー技術は、痛みや不快感を伴わずに慢性疾患患者にインスリンや薬剤を投与するために広く使用されており、治療成績の向上、感染症のリスク低減、患者のQOL向上につながっています。さらに、服薬アドヒアランスの向上、薬剤吸収の増加、治療効果の向上、注射針に伴う合併症の最小化を目的とした技術の採用が広がっていることも、成長を促す要因として作用しています。さらに、レーザーを利用した微細なジェット噴流を皮膚に高精度で噴射する、レーザーを利用したニードルフリー注射技術（NFIT）の最近の市場開拓が、市場成長にプラスの影響を与えています。さらに、人道的でストレスのない方法で動物にワクチン、薬、麻酔を投与するための動物医療における技術利用の増加が、市場成長に好影響を与えています。これとは別に、ニードルフリードラッグデリバリーシステムの採用を促進し、先進技術の市場開拓を支援するための様々な政府イニシアチブの実施は、市場成長に明るい見通しを生み出しています。その他の要因としては、感染症の流行によるワクチン需要の増加、老人人口の増加、ヘルスケア産業の著しい成長、広範な研究開発活動、ニードルフリードラッグデリバリー技術の利点に関する消費者の意識の高まりなどが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • ニードルフリードラッグデリバリー技術の世界市場はこれまでどのように推移してきたのか？
  • 世界のニードルフリードラッグデリバリー技術市場における市場促進要因、抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界のニードルフリードラッグデリバリー技術市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的なニードルフリードラッグデリバリー技術市場を代表する国は？
  • 製品別の市場内訳は？
  • ニードルフリードラッグデリバリー技術市場で最も魅力的な製品は？
  • 用途別の市場内訳は？
  • ニードルフリードラッグデリバリー技術市場で最も魅力的な用途は？
  • エンドユーザー別の市場内訳は？
  • ニードルフリードラッグデリバリー技術市場で最も魅力的なエンドユーザーは？
  • 世界のニードルフリードラッグデリバリー技術市場の競争構造は？
  • ニードルフリードラッグデリバリー技術の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ニードルフリードラッグデリバリー技術の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 吸入器
    • 市場動向
    • 市場予測
  • ジェットインジェクター
    • 市場動向
    • 市場予測
  • 新規ニードル
    • 市場動向
    • 市場予測
  • 経皮吸収パッチ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • ワクチンデリバリー
    • 市場動向
    • 市場予測
  • 疼痛管理
    • 市場動向
    • 市場予測
  • インスリンデリバリー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院・診療所
    • 市場動向
    • 市場予測
  • 在宅ケア環境
    • 市場動向
    • 市場予測
  • 研究ラボ
    • 市場動向
    • 市場予測
  • 学術
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド市場
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Akra Dermojet
    • Antares Pharma Inc.（Halozyme Therapeutics Inc.）
    • Crossject
    • Mika Medical Co.
    • PharmaJet
    • Portal Instruments Inc.

本レポートに掲載されている企業リストは一部です。

図表

List of Figures

  • Figure 1: Global: Needle-free Drug Delivery Technology Market: Major Drivers and Challenges
  • Figure 2: Global: Needle-free Drug Delivery Technology Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Needle-free Drug Delivery Technology Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Needle-free Drug Delivery Technology Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Needle-free Drug Delivery Technology Market: Breakup by End Users (in %), 2022
  • Figure 7: Global: Needle-free Drug Delivery Technology Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Needle-free Drug Delivery Technology (Inhaler) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Needle-free Drug Delivery Technology (Inhaler) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Needle-free Drug Delivery Technology (Jet Injector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Needle-free Drug Delivery Technology (Jet Injector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Needle-free Drug Delivery Technology (Novel Needles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Needle-free Drug Delivery Technology (Novel Needles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Needle-free Drug Delivery Technology (Transdermal Patch) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Needle-free Drug Delivery Technology (Transdermal Patch) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Needle-free Drug Delivery Technology (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Needle-free Drug Delivery Technology (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Needle-free Drug Delivery Technology (Vaccine Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Needle-free Drug Delivery Technology (Vaccine Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Needle-free Drug Delivery Technology (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Needle-free Drug Delivery Technology (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Needle-free Drug Delivery Technology (Insulin Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Needle-free Drug Delivery Technology (Insulin Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Needle-free Drug Delivery Technology (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Needle-free Drug Delivery Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Needle-free Drug Delivery Technology (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Needle-free Drug Delivery Technology (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Needle-free Drug Delivery Technology (Homecare Settings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Needle-free Drug Delivery Technology (Homecare Settings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Needle-free Drug Delivery Technology (Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Needle-free Drug Delivery Technology (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Needle-free Drug Delivery Technology (Academics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Needle-free Drug Delivery Technology (Academics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Needle-free Drug Delivery Technology (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Needle-free Drug Delivery Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Needle-free Drug Delivery Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Needle-free Drug Delivery Technology Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Needle-free Drug Delivery Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Needle-free Drug Delivery Technology Industry: Drivers, Restraints, and Opportunities
  • Figure 86: Global: Needle-free Drug Delivery Technology Industry: Value Chain Analysis
  • Figure 87: Global: Needle-free Drug Delivery Technology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Needle-free Drug Delivery Technology Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by End Users (in Million US$), 2023-2028
  • Table 5: Global: Needle-free Drug Delivery Technology Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Needle-free Drug Delivery Technology Market: Competitive Structure
  • Table 7: Global: Needle-free Drug Delivery Technology Market: Key Players
目次
Product Code: SR112023A7818

The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2023-2028. The escalating prevalence of chronic diseases, the increasing geriatric population, and the recent development of laser-powered needle-free injection technology (NFIT) represent some of the key factors driving the market.

Needle-free drug delivery technology refers to a method of administering medications to patients without using traditional needles. It includes micronozzle jet injectors, transdermal patches, inhalers, disposable cartridge injectors, nasal sprays, and ultrasound waves. They are widely used for vaccinations, insulin delivery, pain management, hormone therapy, and treating allergies, cancer, respiratory conditions, and other chronic diseases. As compared to traditional needle-based delivery systems, needle-free drug delivery technology reduces pain, minimizes discomfort and anxiety, enhances convenience, improves patient compliance, allows dosage customization, and prevents the risk of injuries and infections. It also offers faster medication delivery and aids in enhancing drug absorption, minimizing complications, and increasing treatment effectiveness. Needle-free drug delivery technology is also eco-friendly as it minimizes hazardous waste generation, reduces manufacturing emissions, and eliminates the need for product disposal.

Needle-free Drug Delivery Technology Market Trends:

The escalating prevalence of chronic diseases, such as diabetes, cancer, Crohn's disease, multiple sclerosis, arthritis, osteoporosis, and cardiovascular diseases (CVDs), is one of the primary factors driving the market growth. Needle-free drug delivery technology is widely used to deliver insulin and medications to chronic disease patients without pain and discomfort, which improves treatment outcomes, reduces the risk of infections, and enhances patients' quality of life. Furthermore, the widespread technology adoption to improve medication adherence, increase drug absorption, enhance treatment effectiveness, and minimize complications associated with needles is acting as another growth-inducing factor. Additionally, the recent development of a laser-powered needle-free injection technology (NFIT), which utilizes a laser-based system to blast microscopic jets of drugs into the skin with high precision, is positively influencing the market growth. Moreover, increasing technology utilization in veterinary care to administer vaccines, medications, and anesthesia to animals in a humane and stress-free manner is favoring the market growth. Apart from this, the implementation of various government initiatives to promote the adoption of needle-free drug delivery systems and support the development of advanced technologies are creating a positive outlook for the market growth. Other factors, including rising demand for vaccines due to the increasing prevalence of infectious diseases, increasing geriatric population, significant growth in the healthcare industry, extensive research and development (R&D) activities, and growing consumer awareness regarding the benefits of needle-free drug delivery technology, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global needle-free drug delivery technology market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, application, and end user.

Product Insights:

Inhaler

Jet Injector

Novel Needles

Transdermal Patch

Others

The report has provided a detailed breakup and analysis of the needle-free drug delivery technology market based on the product. This includes inhaler, jet injector, novel needles, transdermal patch, and others.

Application Insights:

Vaccine Delivery

Pain Management

Insulin Delivery

Others

A detailed breakup and analysis of the needle-free drug delivery technology market based on the application has also been provided in the report. This includes vaccine delivery, pain management, insulin delivery, and others.

End User Insights:

Hospitals and Clinics

Homecare Settings

Research Laboratories

Academics

Others

A detailed breakup and analysis of the needle-free drug delivery technology market based on the end user has also been provided in the report. This includes hospitals and clinics, homecare settings, research laboratories, academics, and others.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for needle-free drug delivery technology. Some of the factors driving the North America needle-free drug delivery technology market included the increasing prevalence of chronic diseases, the implementation of various government initiatives, and rapid technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global needle-free drug delivery technology market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Akra Dermojet, Antares Pharma Inc. (Halozyme Therapeutics Inc.), Crossject, Mika Medical Co., PharmaJet, Portal Instruments Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global needle-free drug delivery technology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global needle-free drug delivery technology market?
  • What is the impact of each driver, restraint, and opportunity on the global needle-free drug delivery technology market?
  • What are the key regional markets?
  • Which countries represent the most attractive needle-free drug delivery technology market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the needle-free drug delivery technology market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the needle-free drug delivery technology market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the needle-free drug delivery technology market?
  • What is the competitive structure of the global needle-free drug delivery technology market?
  • Who are the key players/companies in the global needle-free drug delivery technology market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Needle-free Drug Delivery Technology Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Inhaler
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Jet Injector
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Novel Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Transdermal Patch
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7   Market Breakup by Application

  • 7.1  Vaccine Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Insulin Delivery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by End Users

  • 8.1  Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Homecare Settings
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Research Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Academics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5  Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  Drivers, Restraints, and Opportunities

  • 10.1  Overview
  • 10.2  Drivers
  • 10.3  Restraints
  • 10.4  Opportunities

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Akra Dermojet
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2  Antares Pharma Inc. (Halozyme Therapeutics Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3  Crossject
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4  Mika Medical Co.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  PharmaJet
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  Portal Instruments Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.